Life is not so easy....: Individualization in clinical psychopharmacology.
- Published in:
- 2002
- By:
- Publication type:
- Editorial
Works matching IS 00333158 AND DT 2002 AND VI 162 AND IP 1
Results: 21
1
2
Subjective well-being and quality of life under atypical antipsychotic treatment.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 3, doi. 10.1007/s00213-002-1052-z
- By:
- Publication type:
- Article
3
The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 11, doi. 10.1007/s00213-002-1053-y
- By:
- Publication type:
- Article
4
Clinical applications of pharmacogenetics in psychiatry.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 18, doi. 10.1007/s00213-002-1084-4
- By:
- Publication type:
- Article
5
Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 24, doi. 10.1007/s00213-002-1054-x
- By:
- Publication type:
- Article
6
Comparing the efficacy of atypical antipsychotics in open uncontrolled versus double-blind controlled trials in schizophrenia.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 29, doi. 10.1007/s00213-002-1055-9
- By:
- Publication type:
- Article
7
Low striatal and extra-striatal D[sub 2] receptor occupancy during treatment with the atypical antipsychotic sertindole.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 37, doi. 10.1007/s00213-002-1083-5
- By:
- Publication type:
- Article
8
Striatal dopamine-2 receptor occupancy as measured with [[sup 123] I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 42, doi. 10.1007/s00213-002-1082-6
- By:
- Publication type:
- Article
9
Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 50, doi. 10.1007/s00213-002-1056-8
- By:
- Publication type:
- Article
10
Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 55, doi. 10.1007/s00213-002-1057-7
- By:
- Publication type:
- Article
11
Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 63, doi. 10.1007/s00213-002-1058-6
- By:
- Publication type:
- Article
12
Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 67, doi. 10.1007/s00213-002-1059-5
- By:
- Publication type:
- Article
13
A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 74, doi. 10.1007/s00213-002-1068-4
- By:
- Publication type:
- Article
14
Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 82, doi. 10.1007/s00213-002-1060-z
- By:
- Publication type:
- Article
15
Risperidone may induce mania.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 85
- By:
- Publication type:
- Article
16
Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 87, doi. 10.1007/s00213-002-1062-x
- By:
- Publication type:
- Article
17
Clozapine is more efficacious for tongue dystonia than olanzapine.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 89, doi. 10.1007/s00213-002-1063-9
- By:
- Publication type:
- Article
18
Second generation antipsychotics.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 90, doi. 10.1007/s00213-002-1064-8
- By:
- Publication type:
- Article
19
New study designs for new antipsychotics.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 92, doi. 10.1007/s00213-002-1065-7
- By:
- Publication type:
- Article
20
Prolactin secretion is not a core dimension of "atypicality".
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 93, doi. 10.1007/s00213-002-1066-6
- By:
- Publication type:
- Article
21
Olanzapine-induced galactorrhea.
- Published in:
- Psychopharmacology, 2002, v. 162, n. 1, p. 94, doi. 10.1007/s00213-002-1067-5
- By:
- Publication type:
- Article